Frequency of blood CX3CR1‐positive natural killer cells correlates with disease activity in multiple sclerosis patients
- 6 September 2005
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 19 (13) , 1902-1904
- https://doi.org/10.1096/fj.05-3832fje
Abstract
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS) characterized by enormous variability in its clinical presentation and course, and for which clear diagnostic parameters are lacking. Here we performed an RNA screen in peripheral mononuclear cells from relapsing-remitting (RR) and primary progressive (PP) MS patients compared with healthy donors (HD) that indicated, among other findings, a role for the chemokine receptor CX3CR1 as a diagnostic marker. Gene expression and flow cytometric analyses demonstrated a significantly lower expression of CX3CR1 in MS patients compared with healthy individuals. The subpopulation of cells responsible for causing this reduced expression of CX3CR1 consisted exclusively of natural killer (NK) cells. Importantly, we found a correlation between disease activity and frequency of CX3CR1-positive NK cells in RRMS patients. These findings emphasize the role of NK cells in the development and course of MS and provide evidence for CX3CR1 expression as a marker for MS patients and disease activity.Keywords
Funding Information
- Bundesministerium für Bildung und Forschung
- Centros de Investigación y Desarrollo, Universidad de Valparaíso
This publication has 39 references indexed in Scilit:
- Microarray detection of E2F pathway activation and other targets in multiple sclerosis peripheral blood mononuclear cellsJournal of Neuroimmunology, 2004
- Multiple sclerosisJournal of Clinical Investigation, 2004
- Blood transcriptional signatures of multiple sclerosis: Unique gene expression of disease activityAnnals of Neurology, 2004
- Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to diseaseHuman Molecular Genetics, 2003
- Key issues in the diagnosis and treatment of multiple sclerosisNeurology, 2002
- Cutting Edge: Molecular Portrait of Human Autoimmune DiseaseThe Journal of Immunology, 2002
- In vivo gene expression revealed by cDNA arrays: the pattern in relapsing–remitting multiple sclerosis patients compared with normal subjectsJournal of Neuroimmunology, 2001
- Multiple SclerosisNew England Journal of Medicine, 2000
- Fractalkine and CX3CR1 Mediate a Novel Mechanism of Leukocyte Capture, Firm Adhesion, and Activation under Physiologic FlowThe Journal of Experimental Medicine, 1998
- A new class of membrane-bound chemokine with a CX3C motifNature, 1997